How is age-related macular degeneration diagnosed? Which patient is at risk of the disease? What are the treatment options? These, in short, are the questions to which some of the most authoritative have been asked to answerspecialists in ophthalmology, during the webinar recently held within the training course of Floretina 2021, on the topic ‘Neovascular Amd in real life’, chaired by Edoardo Midena, professor of Diseases of the visual apparatus and director of the School of Specialization in Ophthalmology of the University of Padua, and by Stanislao Rizzo, director of the Ophthalmology complex operating unit of the A. Gemelli Irccs University Hospital of Rome, organized with the unconditional contribution of Bayer.
Read Also
- Government entered pension reform project: 6% solidarity and end of the AFPs mark discussion Nov 7, 2022
- The true meaning of the photo of Raffaella Carrà with the children who was near her coffin Jul 10, 2021
- New Toyota Yaris Cross, prices, range and equipment Jul 13, 2021
- Permanent disability pension: how many years do I have to contribute to Social Security to apply for it? Sep 9, 2021
- HS analysis How do you break the vicious circle so that busy caregivers can cope with their work? Recruitment bans are just on Sep 15, 2021
- Where did the ball end up? Real Madrid midfielder stars in the viral of the moment in Spain Nov 8, 2022
- In love?: They caught Dua Lipa and Arón Piper dancing sensually in a Madrid nightclub Jun 4, 2022